Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium thiocyanate (KSCN) is an inorganic salt that serves as a significant component of the ionic milieu in biochemical research, primarily acting as a chaotropic agent (PubChem CID 516871). It functions by disrupting the hydrogen-bonding network of water, which weakens hydrophobic interactions and leads to the denaturation or solubilization of proteins (Hofmeister, 1888). While not a traditional therapeutic target, the thiocyanate ion (SCN-) is physiologically relevant as a competitive inhibitor of the sodium-iodide symporter (NIS) in the thyroid gland, potentially leading to goitrogenic effects (Tonacchera et al., 2004). Furthermore, thiocyanate is a key substrate for mammalian peroxidase enzymes, such as lactoperoxidase and myeloperoxidase, which convert it into the antimicrobial agent hypothiocyanite (OSCN-) as part of the innate immune response (Pruitt et al., 1983). In clinical toxicology, thiocyanate levels in blood or urine are utilized as biomarkers for cyanide exposure and tobacco smoke inhalation (Way, 1984). Excessive accumulation of thiocyanate can result in neurotoxic manifestations, highlighting its importance in environmental and occupational health (Smith, 1973). It is also studied in the context of cystic fibrosis, where impaired thiocyanate transport may contribute to reduced airway host defense (Fragoso et al., 2004). Overall, it is a chemical tool used to probe protein stability rather than a site for drug intervention.
Acts as a chaotropic agent that disrupts the hydrogen-bonding network of water, thereby weakening hydrophobic interactions and promoting protein denaturation (Hofmeister, 1888). It also acts as a competitive inhibitor of the sodium-iodide symporter (NIS), reducing iodine accumulation in the thyroid (Tonacchera et al., 2004).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium thiocyanate (KSCN).